Rotavirus Infection Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Rotavirus Infection Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rotavirus Infection Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rotavirus Infection Therapeutics Overall Market Size
2.1 Global Rotavirus Infection Therapeutics Market Size: 2022 VS 2030
2.2 Global Rotavirus Infection Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rotavirus Infection Therapeutics Players in Global Market
3.2 Top Global Rotavirus Infection Therapeutics Companies Ranked by Revenue
3.3 Global Rotavirus Infection Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Rotavirus Infection Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Rotavirus Infection Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rotavirus Infection Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Rotavirus Infection Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Rotavirus Infection Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rotavirus Infection Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Oral Drug
4.1.3 Injiectable Drug
4.2 By Type - Global Rotavirus Infection Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Rotavirus Infection Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Rotavirus Infection Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rotavirus Infection Therapeutics Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Rotavirus Infection Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Rotavirus Infection Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Rotavirus Infection Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Rotavirus Infection Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Rotavirus Infection Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Rotavirus Infection Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Rotavirus Infection Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Rotavirus Infection Therapeutics Revenue, 2018-2030
6.3.2 US Rotavirus Infection Therapeutics Market Size, 2018-2030
6.3.3 Canada Rotavirus Infection Therapeutics Market Size, 2018-2030
6.3.4 Mexico Rotavirus Infection Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Rotavirus Infection Therapeutics Revenue, 2018-2030
6.4.2 Germany Rotavirus Infection Therapeutics Market Size, 2018-2030
6.4.3 France Rotavirus Infection Therapeutics Market Size, 2018-2030
6.4.4 U.K. Rotavirus Infection Therapeutics Market Size, 2018-2030
6.4.5 Italy Rotavirus Infection Therapeutics Market Size, 2018-2030
6.4.6 Russia Rotavirus Infection Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Rotavirus Infection Therapeutics Market Size, 2018-2030
6.4.8 Benelux Rotavirus Infection Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Rotavirus Infection Therapeutics Revenue, 2018-2030
6.5.2 China Rotavirus Infection Therapeutics Market Size, 2018-2030
6.5.3 Japan Rotavirus Infection Therapeutics Market Size, 2018-2030
6.5.4 South Korea Rotavirus Infection Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Rotavirus Infection Therapeutics Market Size, 2018-2030
6.5.6 India Rotavirus Infection Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Rotavirus Infection Therapeutics Revenue, 2018-2030
6.6.2 Brazil Rotavirus Infection Therapeutics Market Size, 2018-2030
6.6.3 Argentina Rotavirus Infection Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, 2018-2030
6.7.2 Turkey Rotavirus Infection Therapeutics Market Size, 2018-2030
6.7.3 Israel Rotavirus Infection Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Rotavirus Infection Therapeutics Market Size, 2018-2030
6.7.5 UAE Rotavirus Infection Therapeutics Market Size, 2018-2030
7 Rotavirus Infection Therapeutics Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline Rotavirus Infection Therapeutics Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Bharat Biotech
7.2.1 Bharat Biotech Company Summary
7.2.2 Bharat Biotech Business Overview
7.2.3 Bharat Biotech Rotavirus Infection Therapeutics Major Product Offerings
7.2.4 Bharat Biotech Rotavirus Infection Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Bharat Biotech Key News & Latest Developments
7.3 Curevac
7.3.1 Curevac Company Summary
7.3.2 Curevac Business Overview
7.3.3 Curevac Rotavirus Infection Therapeutics Major Product Offerings
7.3.4 Curevac Rotavirus Infection Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Curevac Key News & Latest Developments
7.4 Ology Bioservices
7.4.1 Ology Bioservices Company Summary
7.4.2 Ology Bioservices Business Overview
7.4.3 Ology Bioservices Rotavirus Infection Therapeutics Major Product Offerings
7.4.4 Ology Bioservices Rotavirus Infection Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Ology Bioservices Key News & Latest Developments
7.5 BioKangtai
7.5.1 BioKangtai Company Summary
7.5.2 BioKangtai Business Overview
7.5.3 BioKangtai Rotavirus Infection Therapeutics Major Product Offerings
7.5.4 BioKangtai Rotavirus Infection Therapeutics Revenue in Global Market (2018-2023)
7.5.5 BioKangtai Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Rotavirus Infection Therapeutics Market Opportunities & Trends in Global Market
Table 2. Rotavirus Infection Therapeutics Market Drivers in Global Market
Table 3. Rotavirus Infection Therapeutics Market Restraints in Global Market
Table 4. Key Players of Rotavirus Infection Therapeutics in Global Market
Table 5. Top Rotavirus Infection Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Rotavirus Infection Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Rotavirus Infection Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Rotavirus Infection Therapeutics Product Type
Table 9. List of Global Tier 1 Rotavirus Infection Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rotavirus Infection Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Rotavirus Infection Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Rotavirus Infection Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Rotavirus Infection Therapeutics Product Offerings
Table 32. GlaxoSmithKline Rotavirus Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Bharat Biotech Company Summary
Table 35. Bharat Biotech Rotavirus Infection Therapeutics Product Offerings
Table 36. Bharat Biotech Rotavirus Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Bharat Biotech Key News & Latest Developments
Table 38. Curevac Company Summary
Table 39. Curevac Rotavirus Infection Therapeutics Product Offerings
Table 40. Curevac Rotavirus Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Curevac Key News & Latest Developments
Table 42. Ology Bioservices Company Summary
Table 43. Ology Bioservices Rotavirus Infection Therapeutics Product Offerings
Table 44. Ology Bioservices Rotavirus Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Ology Bioservices Key News & Latest Developments
Table 46. BioKangtai Company Summary
Table 47. BioKangtai Rotavirus Infection Therapeutics Product Offerings
Table 48. BioKangtai Rotavirus Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. BioKangtai Key News & Latest Developments
List of Figures
Figure 1. Rotavirus Infection Therapeutics Segment by Type in 2022
Figure 2. Rotavirus Infection Therapeutics Segment by Application in 2022
Figure 3. Global Rotavirus Infection Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rotavirus Infection Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Rotavirus Infection Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rotavirus Infection Therapeutics Revenue in 2022
Figure 8. By Type - Global Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. GlaxoSmithKline Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bharat Biotech Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Curevac Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ology Bioservices Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BioKangtai Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)